Opthea Ltd (OPT)
3.30
-0.10
(-2.94%)
USD |
NASDAQ |
May 01, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
Opthea Total Return Level: 3.40 for April 30, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 30, 2024 | 3.40 |
April 29, 2024 | 3.27 |
April 26, 2024 | 3.40 |
April 25, 2024 | 3.63 |
April 24, 2024 | 3.43 |
April 23, 2024 | 3.36 |
April 22, 2024 | 3.38 |
April 19, 2024 | 3.30 |
April 18, 2024 | 3.40 |
April 17, 2024 | 3.40 |
April 16, 2024 | 3.54 |
April 15, 2024 | 3.56 |
April 12, 2024 | 3.80 |
April 11, 2024 | 3.90 |
April 10, 2024 | 3.91 |
April 09, 2024 | 4.05 |
April 08, 2024 | 3.75 |
April 05, 2024 | 4.00 |
April 04, 2024 | 3.90 |
April 03, 2024 | 3.95 |
April 02, 2024 | 3.95 |
April 01, 2024 | 4.14 |
March 28, 2024 | 4.11 |
March 27, 2024 | 3.91 |
March 26, 2024 | 3.71 |
Date | Value |
---|---|
March 25, 2024 | 3.70 |
March 22, 2024 | 3.78 |
March 21, 2024 | 3.48 |
March 20, 2024 | 3.46 |
March 19, 2024 | 3.39 |
March 18, 2024 | 3.39 |
March 15, 2024 | 3.45 |
March 14, 2024 | 3.50 |
March 13, 2024 | 3.35 |
March 12, 2024 | 3.33 |
March 11, 2024 | 3.39 |
March 08, 2024 | 3.33 |
March 07, 2024 | 3.35 |
March 06, 2024 | 3.21 |
March 05, 2024 | 3.47 |
March 04, 2024 | 3.41 |
March 01, 2024 | 3.52 |
February 29, 2024 | 3.65 |
February 28, 2024 | 3.61 |
February 27, 2024 | 3.53 |
February 26, 2024 | 3.27 |
February 23, 2024 | 3.43 |
February 22, 2024 | 3.23 |
February 21, 2024 | 3.315 |
February 20, 2024 | 3.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.60
Minimum
Oct 20 2023
21.22
Maximum
Sep 09 2019
7.733
Average
6.50
Median
Feb 07 2022
Total Return Level Benchmarks
Immutep Ltd | 2.67 |
Kazia Therapeutics Ltd | 0.3348 |
Bionomics Ltd | 0.95 |
Alterity Therapeutics Ltd | 2.095 |
Mesoblast Ltd | 6.60 |